Review
doi: 10.1016/j.urolonc.2008.11.002.
Epub 2009 Jan 22.
Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer
Affiliations
- PMID: 19162510
- DOI: 10.1016/j.urolonc.2008.11.002
Item in Clipboard
Review
Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer
Urol Oncol.
2009 Nov-Dec.
Abstract
The peroxisome proliferator-activated receptor (PPAR) family is an important group of transcription factors that regulates immune surveillance, cell proliferation, fatty acid regulation, and angiogenesis--functions which have all been implicated in the pathogenesis of bladder cancer. One particular subtype, PPARgamma, is expressed at higher levels in bladder cancer specimens than in benign urothelium, and is an attractive molecular target for the development of novel treatment strategies for bladder cancer. In this review, we summarize the data available regarding relevance of PPARgamma in bladder cancer and discuss the potential value of PPAR-targeted treatment of bladder cancer.
Similar articles
-
Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells.Int J Mol Med. 2006 Feb;17(2):269-73. Int J Mol Med. 2006. PMID: 16391825
-
Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.Cancer Res. 2006 Jan 1;66(1):412-8. doi: 10.1158/0008-5472.CAN-05-2755. Cancer Res. 2006. PMID: 16397256
-
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?Anticancer Drugs. 2007 Mar;18(3):237-44. doi: 10.1097/CAD.0b013e328011e67d. Anticancer Drugs. 2007. PMID: 17264754 Review.
-
Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.Endocr Relat Cancer. 2006 Jun;13(2):401-13. doi: 10.1677/erc.1.01182. Endocr Relat Cancer. 2006. PMID: 16728570 Review.
-
Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.Toxicol Appl Pharmacol. 2007 Sep 15;223(3):246-56. doi: 10.1016/j.taap.2007.06.015. Epub 2007 Jul 3. Toxicol Appl Pharmacol. 2007. PMID: 17663016
Cited by
-
Adiponectin retards the progression of diabetic nephropathy in db/db mice by counteracting angiotensin II.Physiol Rep. 2014 Feb 10;2(2):e00230. doi: 10.1002/phy2.230. eCollection 2014 Feb 1. Physiol Rep. 2014. PMID: 24744899 Free PMC article.
-
Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model.Investig Clin Urol. 2018 Jul;59(4):257-262. doi: 10.4111/icu.2018.59.4.257. Epub 2018 Jun 15. Investig Clin Urol. 2018. PMID: 29984341 Free PMC article.
-
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping.Res Sq [Preprint]. 2024 Apr 10:rs.3.rs-3994376. doi: 10.21203/rs.3.rs-3994376/v1. Res Sq. 2024. PMID: 38659962 Free PMC article. Preprint.
-
DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.BMC Res Notes. 2012 Oct 31;5:607. doi: 10.1186/1756-0500-5-607. BMC Res Notes. 2012. PMID: 23114535 Free PMC article.
-
A novel peroxisome-related gene signature predicts clinical prognosis and is associated with immune microenvironment in low-grade glioma.PeerJ. 2024 Feb 20;12:e16874. doi: 10.7717/peerj.16874. eCollection 2024. PeerJ. 2024. PMID: 38406287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
